Macrogenics (NASDAQ: MGNX) reported Q2 EPS of ($1.03), $0.19 better than the analyst estimate of ($1.22). Revenue for the quarter came in at $18.8 million versus the consensus estimate of $4.21 million.

For earnings history and earnings-related data on Macrogenics (MGNX) click here.